ClinConnect ClinConnect Logo
Search / Trial NCT02487212

Treatment of Hypertrophic Scars Using Fractional Laser and Fractional Laser-assisted Topical Corticosteroid Delivery

Launched by MAHIDOL UNIVERSITY · Jun 30, 2015

Trial Information

Current as of June 14, 2025

Completed

Keywords

Fractional Laser Hypertrophic Scar Topical Corticosteroid Laser Assisted Delivery Systems

ClinConnect Summary

Hypertrophic scars are common conditions that cause persistent symptom and can lead to severe psychosocial impairment. Intralesional corticosteroid have been a mainstay in the treatment of hypertrophic scars. However, there are many disadvantages of corticosteroid injection such as severe pain, skin atrophy, skin thinning, steroid acne, telangiectasia and hypopigmentation.

Recent reports propose new treatment methods for hypertrophic scars with the use of fractional ablative lasers to create zones of ablation of the skin that may assisted the penetration of drugs to the skin.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Female subjects with age range 18-60 years;
  • Subject with hypertrophic scar from abdominal surgery for at least 3 months;
  • Discontinued using oral isotretinoin for 6 months, alpha hydroxy acid or topical retinoic acid for 3 months
  • Exclusion Criteria:
  • Subject who has skin Infection, photosensitive dermatosis or inflammatory acne on the treated area;
  • Subject who smoke cigarette;
  • Subject who was treated with Intralesional corticosteroid

About Mahidol University

Mahidol University, a premier institution in Thailand, is dedicated to advancing healthcare through innovative research and education. As a leading sponsor of clinical trials, the university leverages its extensive expertise in medical and health sciences to facilitate rigorous scientific investigations aimed at improving patient care and public health outcomes. With a commitment to ethical practices and collaboration, Mahidol University fosters multidisciplinary approaches, engaging a diverse array of researchers and healthcare professionals to drive meaningful advancements in clinical research.

Locations

Bangkok, , Thailand

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials